Delivery Order SPE2DR25D3103-SPE2DR26F9L90
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Janumet 50-1,000 mg tablets in a quantity of 180 units, with a ceiling value of $1,730.18. This firm fixed-price delivery order, without set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet 50-1,000 mg tablets in quantities of 1,000 units, with a ceiling value of $2,012.06. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count packaging) with a ceiling value of $6,703.49. This firm fixed-price delivery order, set to be completed by November 14, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply relationship with the federal government. The contract utilizes a non-set-aside, competitively awarded structure and will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $14,237.99. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract represents a single delivery order placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a ceiling value of $1,130.90. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 23, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Janumet 50-1,000 mg tablets (60-count units) with a ceiling value of $2,044.98. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by September 29, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a contract value of $4,939.13. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The ultimate completion date is September 16, 2025, and the work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on September 8, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $3,223.51. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 9, 2025, and is being performed at the contractor's Conshohocken facility. No set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $1,363.33. This is a firm fixed-price delivery order with no set-aside designation, placing performance in Conshohocken, Pennsylvania, with an ultimate completion date of November 25, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9L90Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Janumet 50-1,000 mg tablets (60-count units) with a contract ceiling value of $4,606.94. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 5, 2025. This delivery order supports the Defense Health Agency and military healthcare systems' pharmaceutical supply requirements. Janumet is a combination diabetes medication used in the treatment and management of type 2 diabetes. AmerisourceBergen, as a major pharmaceutical distributor, maintains an extensive portfolio of federal medical supply contracts with DLA, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The $1 billion SPE2DX IDC serves as the overarching contract vehicle enabling AmerisourceBergen to fulfill diverse pharmaceutical and medical commodity needs for military healthcare programs worldwide through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 12/3/25 |